Drugs Made In America Acquisition II Corp. Ordinary Shares
General ticker "DMII" information:
- Sector: Financials
- Industry: Financial - Conglomerates
- Capitalization: $496.4M (TTM average)
Drugs Made In America Acquisition II Corp. Ordinary Shares follows the US Stock Market performance with the rate: 43.6%.
Estimated limits based on current volatility of 0.1%: low 10.22$, high 10.23$
Short-term DMII quotes
Long-term DMII plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $0.15MM |
| Operating Income | $-0.15MM |
| Income(Loss) | $-0.15MM |
| Net Income(Loss)* | $-0.15MM |
| Stockholders Equity | $-0.12MM |
| Assets | $0.14MM |
| Operating Cash Flow | $-0.19MM |
| Financing Cash Flow | $0.21MM |
| Earnings Per Share** | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.